Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,168 | -10,083 | -6,744 | -4,414 | -1,965 |
| Accounts payable and accrued liabilities | 34 | 33 | 6 | 29 | 23 |
| Other Working Capital | -259 | -215 | -779 | -866 | -739 |
| Other Operating Activity | 207 | 2,257 | 1,802 | 1,232 | 628 |
| Operating Cash Flow | $-2,186 | $-8,008 | $-5,715 | $-4,019 | $-2,053 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,291 | -12,699 | -10,516 | -3,186 | -2,446 |
| Sale Of Investment | 6,490 | 15,657 | 11,678 | 7,428 | 2,703 |
| Investing Cash Flow | $2,199 | $2,958 | $1,162 | $4,242 | $257 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | -134 | -134 | 0 |
| Financing Cash Flow | $N/A | $N/A | $-134 | $-134 | $N/A |
| Exchange Rate Effect | 15 | -224 | -339 | -129 | -16 |
| Beginning Cash Position | 6,888 | 12,162 | 12,162 | 12,162 | 12,162 |
| End Cash Position | 6,916 | 6,888 | 7,136 | 12,122 | 10,350 |
| Net Cash Flow | $28 | $-5,274 | $-5,026 | $-40 | $-1,812 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,186 | -8,008 | -5,715 | -4,019 | -2,053 |
| Free Cash Flow | -2,186 | -8,008 | -5,715 | -4,019 | -2,053 |